SG11202108502UA - Polynucleotides - Google Patents
PolynucleotidesInfo
- Publication number
- SG11202108502UA SG11202108502UA SG11202108502UA SG11202108502UA SG11202108502UA SG 11202108502U A SG11202108502U A SG 11202108502UA SG 11202108502U A SG11202108502U A SG 11202108502UA SG 11202108502U A SG11202108502U A SG 11202108502UA SG 11202108502U A SG11202108502U A SG 11202108502UA
- Authority
- SG
- Singapore
- Prior art keywords
- polynucleotides
- Prior art date
Links
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01045—Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1901512.2A GB201901512D0 (en) | 2019-02-04 | 2019-02-04 | Polynucleotides |
GBGB1917910.0A GB201917910D0 (en) | 2019-12-06 | 2019-12-06 | Polynucleotides |
PCT/GB2020/050251 WO2020161483A1 (en) | 2019-02-04 | 2020-02-04 | Polynucleotides |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202108502UA true SG11202108502UA (en) | 2021-09-29 |
Family
ID=69591668
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202108502UA SG11202108502UA (en) | 2019-02-04 | 2020-02-04 | Polynucleotides |
Country Status (19)
Country | Link |
---|---|
US (1) | US20220154159A1 (en) |
EP (2) | EP4299116A3 (en) |
JP (1) | JP7600124B2 (en) |
KR (1) | KR20210148101A (en) |
CN (1) | CN113795575A (en) |
AU (1) | AU2020217894A1 (en) |
BR (1) | BR112021015312A2 (en) |
CA (1) | CA3128875A1 (en) |
DK (1) | DK3850089T5 (en) |
ES (1) | ES2968922T3 (en) |
FI (1) | FI3850089T3 (en) |
HR (1) | HRP20240184T1 (en) |
HU (1) | HUE065347T2 (en) |
IL (1) | IL285350B1 (en) |
MX (1) | MX2021009305A (en) |
PL (1) | PL3850089T3 (en) |
PT (1) | PT3850089T (en) |
SG (1) | SG11202108502UA (en) |
WO (1) | WO2020161483A1 (en) |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001036603A2 (en) * | 1999-11-17 | 2001-05-25 | Avigen, Inc. | Recombinant adeno-associated virus virions for the treatment of lysosomal disorders |
EP1319082B1 (en) * | 2000-09-18 | 2005-11-16 | Genzyme Corporation | Expression vectors containing hybrid ubiquitin promoters |
US20040009151A1 (en) * | 2002-04-04 | 2004-01-15 | Kay Mark A. | Methods for delivering recombinant adeno-associated virus virions to the liver of a mammal |
US20050265988A1 (en) * | 2004-03-18 | 2005-12-01 | Byung-Kwon Choi | Glycosylated glucocerebrosidase expression in fungal hosts |
CA3069431A1 (en) | 2007-04-03 | 2008-10-09 | Oxyrane Uk Limited | Glycosylation of molecules |
JP5291093B2 (en) | 2007-05-16 | 2013-09-18 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | Treatment of synucleinopathy |
EP2365796A4 (en) * | 2008-11-07 | 2015-04-29 | Childrens Hosp Medical Center | FUSOGENIC PROPERTIES OF SAPOSIN C AND RELATED PROTEINS AND PEPTIDES FOR APPLICATION TO TRANSMEMBRANE DRUG DELIVERY SYSTEMS |
KR20180108886A (en) | 2010-03-23 | 2018-10-04 | 인트렉손 코포레이션 | Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof |
WO2011122950A1 (en) | 2010-04-01 | 2011-10-06 | Amsterdam Molecular Therapeutics (Amt) Ip B.V. | Monomeric duplex aav vectors |
US10648001B2 (en) * | 2012-07-11 | 2020-05-12 | Sangamo Therapeutics, Inc. | Method of treating mucopolysaccharidosis type I or II |
ES2745566T3 (en) * | 2013-06-11 | 2020-03-02 | Portage Pharmaceuticals Ltd | Structure, Manufacture, and Uses of Peptides that Can Penetrate Human-derived Cells Conjugated to Specific Biologically Active Charging Peptides |
CA2927366A1 (en) * | 2013-10-24 | 2015-04-30 | Uniqure Ip B.V. | Aav-5 pseudotyped vector for gene therapy for neurological diseases |
US10335466B2 (en) * | 2014-11-05 | 2019-07-02 | Voyager Therapeutics, Inc. | AADC polynucleotides for the treatment of parkinson's disease |
CA2974050A1 (en) * | 2015-03-17 | 2016-09-22 | Greenovation Biotech Gmbh | Glycosylated lysosomal proteins, method of production and uses |
WO2017048495A1 (en) * | 2015-09-14 | 2017-03-23 | Children's Hospital Medical Center | Methods and compositions for treatment of gaucher disease via modulation of c5a receptor |
CA3039673A1 (en) * | 2016-10-20 | 2018-04-26 | Sangamo Therapeutics, Inc. | Methods and compositions for the treatment of fabry disease |
AU2018264581B2 (en) | 2017-05-11 | 2022-05-19 | Zentrum Für Forschungsförderung In Der Pädiatrie Gmbh | Concept for the treatment of monogenetic disorders |
US11597917B2 (en) * | 2017-07-06 | 2023-03-07 | The Medical College Of Wisconsin, Inc. | In vitro and in vivo enrichment strategy targeting lymphocytes derived from vector transduced HSCs for therapy of disorders |
-
2020
- 2020-02-04 SG SG11202108502UA patent/SG11202108502UA/en unknown
- 2020-02-04 CA CA3128875A patent/CA3128875A1/en active Pending
- 2020-02-04 BR BR112021015312A patent/BR112021015312A2/en unknown
- 2020-02-04 JP JP2021545956A patent/JP7600124B2/en active Active
- 2020-02-04 MX MX2021009305A patent/MX2021009305A/en unknown
- 2020-02-04 WO PCT/GB2020/050251 patent/WO2020161483A1/en active Application Filing
- 2020-02-04 KR KR1020217028360A patent/KR20210148101A/en active Pending
- 2020-02-04 US US17/428,344 patent/US20220154159A1/en active Pending
- 2020-02-04 CN CN202080017551.2A patent/CN113795575A/en active Pending
- 2020-02-04 AU AU2020217894A patent/AU2020217894A1/en active Pending
- 2020-02-04 HU HUE20705470A patent/HUE065347T2/en unknown
- 2020-02-04 FI FIEP20705470.1T patent/FI3850089T3/en active
- 2020-02-04 EP EP23207775.0A patent/EP4299116A3/en active Pending
- 2020-02-04 PL PL20705470.1T patent/PL3850089T3/en unknown
- 2020-02-04 HR HRP20240184TT patent/HRP20240184T1/en unknown
- 2020-02-04 PT PT207054701T patent/PT3850089T/en unknown
- 2020-02-04 DK DK20705470.1T patent/DK3850089T5/en active
- 2020-02-04 ES ES20705470T patent/ES2968922T3/en active Active
- 2020-02-04 IL IL285350A patent/IL285350B1/en unknown
- 2020-02-04 EP EP20705470.1A patent/EP3850089B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
DK3850089T3 (en) | 2024-02-12 |
CA3128875A1 (en) | 2020-08-13 |
IL285350B1 (en) | 2025-03-01 |
US20220154159A1 (en) | 2022-05-19 |
JP2022520179A (en) | 2022-03-29 |
PT3850089T (en) | 2024-01-24 |
CN113795575A (en) | 2021-12-14 |
ES2968922T3 (en) | 2024-05-14 |
EP4299116A2 (en) | 2024-01-03 |
WO2020161483A1 (en) | 2020-08-13 |
JP7600124B2 (en) | 2024-12-16 |
MX2021009305A (en) | 2021-11-04 |
HRP20240184T1 (en) | 2024-04-26 |
BR112021015312A2 (en) | 2021-11-09 |
FI3850089T3 (en) | 2024-02-14 |
EP3850089B1 (en) | 2023-12-13 |
KR20210148101A (en) | 2021-12-07 |
EP4299116A3 (en) | 2024-06-19 |
HUE065347T2 (en) | 2024-05-28 |
PL3850089T3 (en) | 2024-05-06 |
DK3850089T5 (en) | 2024-08-19 |
AU2020217894A1 (en) | 2021-08-26 |
EP3850089A1 (en) | 2021-07-21 |
IL285350A (en) | 2021-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3958977T3 (en) | Camptothecinderivater | |
CA196372S (en) | Soundbar | |
CA189498S (en) | Showerbase | |
CA191618S (en) | Floorwasher - nozzle | |
DK3980417T3 (en) | PRMT5-Inhibitorer | |
DK4119172T3 (en) | Automatisk injektionssystem | |
DK3942152T3 (en) | Tætninger | |
CA189677S (en) | Uroflowmeter | |
CA201156S (en) | Banquette | |
GB201901778D0 (en) | Aladin | |
CA190552S (en) | Hand-dryer | |
CA189795S (en) | Handshower | |
CA193248S (en) | Mandoline | |
CA190384S (en) | Beverageware | |
CA190385S (en) | Beverageware | |
CA190387S (en) | Beverageware | |
CA189047S (en) | Hammock-tent | |
GB201900347D0 (en) | Blazeloc | |
SG11202108502UA (en) | Polynucleotides | |
GB201917910D0 (en) | Polynucleotides | |
GB201901512D0 (en) | Polynucleotides | |
CA194482S (en) | Kick-scooter | |
DK3832828T3 (en) | Strømforyningsnetsystem | |
CA192228S (en) | Hydrogenerator | |
CA190974S (en) | Hoodie |